Atlas Trials

One Month Dual Antiretroviral Prophylaxis to Prevent Resistance Mutations in Mothers Exposed to Single Dose Nevirapine

Clinical trial NCT00142337 · COMPLETED

Trial details

NCT number
NCT00142337
Sponsor
Institut de Recherche pour le Developpement
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
HIV Infections
Start date
2004-12-01
Primary completion
2006-05-01
Enrollment
244

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.